Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11028477 | Clinical and Translational Radiation Oncology | 2018 | 9 Pages |
Abstract
DWI has shown promise for RT outcome prediction, response assessment, as well as for tumor delineation and characterization in several cancer types. Geometric and quantification robustness is challenging and has to be addressed adequately. Evaluation in larger clinical trials with well designed imaging protocol and advanced analysis models is needed to develop the optimal strategy for integrating DWI in RT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sara Leibfarth, René M. Winter, Heidi Lyng, Daniel Zips, Daniela Thorwarth,